Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis (OARS)
Primary Purpose
Anterior Vaginal Wall Prolapse, Cystocele, Pelvic Organ Prolapse
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Polypropylene mesh (Polyform by Boston Scientific)
Porcine Dermis (Pelvicol by CRBard)
Anterior Colporrhaphy
Sponsored by
About this trial
This is an interventional treatment trial for Anterior Vaginal Wall Prolapse focused on measuring Anterior Vaginal Prolapse, Cystocele, Pelvic Organ Prolapse
Eligibility Criteria
Inclusion Criteria:
- Stage 2 or > anterior vaginal prolapse requiring surgical correction.
- >18 years old
- willing to return for follow-up visits.
Exclusion Criteria:
- Less than stage II or > anterior vaginal prolapse,
- decline to participate,
- pregnant or contemplating future pregnancy,
- anti-incontinence procedure other than midurethral sling (ie, Burch colposuspension, pubovaginal sling, or needle suspension) is planned as part of their surgical procedures,
- any contra-indication to receiving mesh or porcine dermis.
Sites / Locations
- Kaiser Permanente
- Kaiser Permanente
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Placebo Comparator
Active Comparator
Arm Label
Polypropylene Mesh
Anterior Colporrhaphy
Porcine Dermis
Arm Description
Site-specific cystocele repair with polypropylene mesh augmentation
Anterior vaginal prolapse repair with anterior colporrhaphy with no graft.
Site-specific cystocele repair with porcine dermis augmentation
Outcomes
Primary Outcome Measures
Prospective Randomized Trial of Anterior Colporrhaphy Vs. Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
The primary outcome of this investigation will be postoperative anterior vaginal support measured by the validated scale(POP-Q, POP-Q point Ba performed by blinded examiner. Anatomic support will be considered optimal when Ba by POP-Q being at stage 0 or 1 (Ba=-2,-3).
Secondary Outcome Measures
Adverse events
Secondary outcomes include
*hospital data including intra-operative data complications (genito-urinary tract injury) and estimated blood loss. Postoperative length of stay.
Overall failure rate
Secondary Outcome Include:
*Overall Failure rate which includes subjective symptoms of vaginal bulge and anatomic/objective measure, POP-Q point of Ba. This secondary outcome represents a composite outcome.
Postoperative quality of life
Secondary Outcome include:
*Quality Of Life- A secondary outcome on subjective bother involving pelvic floor disorders using several validated scales including PFDI-20 and PFIQ-7 will be measured at 6 months, 12 months and 24 months.
Postoperative sexual function
Secondary Outcome Include:
*Sexual Function: A secondary outcome on subjective bother involving pelvic floor disorders using a validated scale, PISQ-12 questionnaire,will be measured at 6 months, 12 months and 24 months.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01393171
Brief Title
Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
Acronym
OARS
Official Title
Prospective Randomized Trial of Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
October 2005 (Actual)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
April 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Permanente
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the success rate of cystocele repair using polypropylene mesh or porcine dermis compared to that of anterior colporrhaphy in a prospective randomized fashion. The study will be performed in a randomized, prospective, single-blinded fashion.
Detailed Description
Study participants will be recruited from the urogynecology clinic at Kaiser Permanente Medical Center Bellflower and San Diego. Clinical evaluation of each patient will include a standardized history, voiding diary, quality of life (UDI-6 & IIQ-7)10 and sexual function (PISQ-12)11-12 questionnaires (Attachment 1), urinalysis, gynecologic and pelvic organ prolapse quantification (POPQ) examinations. Patients will be randomized by a computer-generated randomization schedule, with allocation to either anterior colporrhaphy or site-specific cystocele repair with polypropylene mesh augmentation or site-specific cystocele repair with porcine dermis augmentation. The allocated treatment arm will be concealed in a sealed opaque envelope until the day of surgery. Patients will be given vaginal estrogen cream starting six weeks prior to surgery. Intravenous antibiotic prophylaxis will be given preoperatively and continued postoperatively for 24 hours. Vaginal infiltration will be performed with 0.25% bupivacaine and epinephrine (1:200,000) solution. Anterior colporrhaphy is performed by making a midline incision through the anterior vaginal mucosa, dissecting the vaginal epithelium from the underlying muscularis, and midline plication of the muscularis with No. 2-0 polydioxanone sutures (Ethicon, Somerville, NJ). The excess vaginal mucosa is then excised and the margins of the vagina reapproximated in the midline using No. 2-0 polyglactin (Vicryl) sutures. Patients who are randomized to polypropylene mesh or porcine dermis repair will undergo a site-specific defect repair of the vaginal muscularis with No. 2-0 polydioxanone sutures after midline vaginal incision and lateral dissection. A piece of the assigned material will be fashioned to fit the repaired space and anchored bilaterally to the arcus tendineus fascia pelvis with interrupted No. 2-0 polydioxanone sutures. Other operative procedures will be performed as indicated. TVT or TVT-O procedures (Gynecare Inc., Somerville, NJ) will be performed for stress urinary incontinence as previously described through a separate midurethral vaginal incision. The vagina will be packed for 24 hours. All patients will be discharged when they are able to ambulate and tolerate a solid diet and oral pain medication.
The two groups will be evaluated at 6 weeks, 6 months, 1 and 2 years after surgery. A trained clinical nurse/clinical fellow, whom has been proctored in performance of POP-Q exams, will perform postoperative POPQ staging in all patients. A research nurse blinded to the subject's group assignment will administer preoperative and postoperative quality of life and sexual function questionnaires. The primary outcome of this investigation will be postoperative anterior vaginal support. Anatomic success is defined as point Ba< -1. Secondary outcomes including hospital data, complications, subjective continence, quality of life and sexual function, and overall satisfaction with surgery, will also be compared.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anterior Vaginal Wall Prolapse, Cystocele, Pelvic Organ Prolapse
Keywords
Anterior Vaginal Prolapse, Cystocele, Pelvic Organ Prolapse
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Polypropylene Mesh
Arm Type
Active Comparator
Arm Description
Site-specific cystocele repair with polypropylene mesh augmentation
Arm Title
Anterior Colporrhaphy
Arm Type
Placebo Comparator
Arm Description
Anterior vaginal prolapse repair with anterior colporrhaphy with no graft.
Arm Title
Porcine Dermis
Arm Type
Active Comparator
Arm Description
Site-specific cystocele repair with porcine dermis augmentation
Intervention Type
Device
Intervention Name(s)
Polypropylene mesh (Polyform by Boston Scientific)
Other Intervention Name(s)
Polyform by Boston Scientific
Intervention Description
Site-specific cystocele repair with polypropylene mesh augmentation
Intervention Type
Procedure
Intervention Name(s)
Porcine Dermis (Pelvicol by CRBard)
Other Intervention Name(s)
Pelvicol by CRBard
Intervention Description
Site-specific cystocele repair with porcine dermis augmentation
Intervention Type
Procedure
Intervention Name(s)
Anterior Colporrhaphy
Other Intervention Name(s)
Cystocele repair
Intervention Description
Anterior vaginal prolapse repair with suture.
Primary Outcome Measure Information:
Title
Prospective Randomized Trial of Anterior Colporrhaphy Vs. Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
Description
The primary outcome of this investigation will be postoperative anterior vaginal support measured by the validated scale(POP-Q, POP-Q point Ba performed by blinded examiner. Anatomic support will be considered optimal when Ba by POP-Q being at stage 0 or 1 (Ba=-2,-3).
Time Frame
5 years
Secondary Outcome Measure Information:
Title
Adverse events
Description
Secondary outcomes include
*hospital data including intra-operative data complications (genito-urinary tract injury) and estimated blood loss. Postoperative length of stay.
Time Frame
5 years
Title
Overall failure rate
Description
Secondary Outcome Include:
*Overall Failure rate which includes subjective symptoms of vaginal bulge and anatomic/objective measure, POP-Q point of Ba. This secondary outcome represents a composite outcome.
Time Frame
5 year
Title
Postoperative quality of life
Description
Secondary Outcome include:
*Quality Of Life- A secondary outcome on subjective bother involving pelvic floor disorders using several validated scales including PFDI-20 and PFIQ-7 will be measured at 6 months, 12 months and 24 months.
Time Frame
5 Year
Title
Postoperative sexual function
Description
Secondary Outcome Include:
*Sexual Function: A secondary outcome on subjective bother involving pelvic floor disorders using a validated scale, PISQ-12 questionnaire,will be measured at 6 months, 12 months and 24 months.
Time Frame
5 year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Stage 2 or > anterior vaginal prolapse requiring surgical correction.
>18 years old
willing to return for follow-up visits.
Exclusion Criteria:
Less than stage II or > anterior vaginal prolapse,
decline to participate,
pregnant or contemplating future pregnancy,
anti-incontinence procedure other than midurethral sling (ie, Burch colposuspension, pubovaginal sling, or needle suspension) is planned as part of their surgical procedures,
any contra-indication to receiving mesh or porcine dermis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John N. Nguyen, MD
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente
City
Downey
State/Province
California
ZIP/Postal Code
90242
Country
United States
Facility Name
Kaiser Permanente
City
San Diego
State/Province
California
ZIP/Postal Code
92110
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22067717
Citation
Menefee SA, Dyer KY, Lukacz ES, Simsiman AJ, Luber KM, Nguyen JN. Colporrhaphy compared with mesh or graft-reinforced vaginal paravaginal repair for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol. 2011 Dec;118(6):1337-1344. doi: 10.1097/AOG.0b013e318237edc4.
Results Reference
derived
Learn more about this trial
Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
We'll reach out to this number within 24 hrs